Chapter

Cardioprotection During Cardiac Surgery

John Pepper

in Cardioprotection

Published on behalf of Oxford University Press

Published in print August 2009 | ISBN: 9780199544769
Published online May 2011 | e-ISBN: 9780191740107 | DOI: http://dx.doi.org/10.1093/med/9780199544769.003.0007

Series: Oxford Cardiology Library

Cardioprotection During Cardiac Surgery

Show Summary Details

Preview

Overall early mortality for cardiac surgery is low at 2–3% but in high risk patients it can be high as 10–15%

The demography of cardiac surgical patients is changing to older and sicker patients

Myocardial ischaemia-reperfusion injury and the systemic inflammatory response are closely related

Several pharmacological agents that have been demon-strated to confer cardioprotection in the experimental setting have been applied to the clinical setting of cardiac surgery. However, the transfer of these findings from the bench to the bedside has been largely disappointing

Potential cardioprotective strategies include pharma-cological agents such as adenosine, and mechanical interventional strategies such as acute normovolaemic haemodilution and remote ischaemic preconditioning.

Chapter.  3127 words.  Illustrated.

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.